BIO-TECHNE Corp

TECH 10-K · Q4 2025
API behind this page

TECH Q4 2025 request

Playground key active
Request URL /api/financials?ticker=TECH&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 316,964 306,099 +3.5%
Show Product Lines breakouts
Consumables 252,941 245,775 +2.9%
Instruments 28,901 27,092 +6.7%
Product and Services 311,459 301,048 +3.5%
Royalty 5,505 5,051 +9.0%
Service 29,617 28,181 +5.1%
Show Business Segments breakouts
Diagnostics and Spatial Biology · Operating Segments 89,705 90,677 -1.1%
Protein Sciences · Operating Segments 226,471 213,988 +5.8%
Show Geography breakouts
APAC, excluding Greater China 18,886 19,259 -1.9%
CN 26,906 23,925 +12.5%
EMEA, excluding United Kingdom 70,349 63,566 +10.7%
GB 14,788 11,763 +25.7%
Rest of World 9,647 10,052 -4.0%
US 176,388 177,534 -0.6%
Show Consolidation Items breakouts
Intersegment Elimination 788 -626 +225.9%
Cost of Revenue 118,152 102,751 +15.0%
Gross Profit 198,812 203,348 -2.2%
Selling, General & Administrative 196,640 133,536 +47.3%
Show — breakouts
Selling, General & Administrative 2,847 1,597 +78.3%
Selling, General & Administrative 130,862 119,586 +9.4%
Selling, General & Administrative 223,817 209,690 +6.7%
Research And Development Expense Excluding Acquired In Process Cost 26,032 23,989 +8.5%
Operating Expenses 222,672 157,525 +41.4%
Operating Income -23,860 45,823 -152.1%
Show Business Segments breakouts
Diagnostics and Spatial Biology · Operating Segments 5,384 11,357 -52.6%
Protein Sciences · Operating Segments 98,789 91,998 +7.4%
Show Consolidation Items breakouts
Operating Segments 104,173 103,355 +0.8%
Interest Expense -2,178 -2,509 +13.2%
Non-Operating Income (Expense) 1,001 -4,162 +124.1%
Income Before Taxes -22,859 41,661 -154.9%
Income Tax Expense (Benefit) -5,181 1,073 -582.9%
Net Income -17,678 40,588 -143.6%
Net Income -17,678 40,588 -143.6%
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent 22,953 -1,934 +1286.8%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent -781 -1,075 +27.3%
Other Comprehensive Income Loss Net Of Tax 22,172 -3,009 +836.9%
Other Comprehensive Income (Q) — — —
Show Equity Components breakouts
Accumulated Net Unrealized Investment Gain Loss -781 -1,075 +27.3%
Accumulated Other Comprehensive Income 22,172 -3,009 +836.9%
Accumulated Translation Adjustment 22,953 -1,934 +1286.8%
Comprehensive Income 4,494 37,579 -88.0%
EPS (Basic) -0.11 0.26 -142.3%
EPS (Diluted) -0.11 0.26 -142.3%
Wtd Avg Shares (Basic) -596 53 -1224.5%
Wtd Avg Shares (Diluted) -945 -43 -2097.7%
Income Loss From Equity Method Investments 1,107 -891 +224.2%
Net Income Loss Available To Common Stockholders Basic -17,701 40,579 -143.6%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 162,186 151,791 +6.8%
Accounts Receivable 206,876 241,394 -14.3%
Inventory 189,446 179,731 +5.4%
Assets Of Disposal Group Including Discontinued Operation Current 12,332 9,773 +26.2%
Other Assets Current 37,460 33,658 +11.3%
Total Current Assets 608,300 617,419 -1.5%
Non-Current Assets
Property, Plant & Equipment 245,719 251,154 -2.2%
Operating Lease Right-of-Use Assets 73,399 91,285 -19.6%
Goodwill 980,935 972,663 +0.9%
Show Business Segments breakouts
Diagnostics and Spatial Biology 554,159 549,214 +0.9%
Protein Sciences 426,776 423,449 +0.8%
Show Business Acquisition breakouts
Lunaphore Technologies SA. 104,650 — —
Deferred Tax Assets 10,307 — —
Other Non-Current Assets 273,609 264,265 +3.5%
Total Assets 2,557,868 2,703,867 -5.4%
Intangible Assets 365,599 — —
Other Assets
Intangible Assets Net Excluding Goodwill 365,599 507,081 -27.9%
Show Geography breakouts
Europe 63,628 63,138 +0.8%
United States and Canada 301,971 443,740 -31.9%
Current Liabilities
Accounts Payable 25,311 37,968 -33.3%
Employee Related Liabilities Current 65,791 49,818 +32.1%
Accrued Liabilities 25,663 24,886 +3.1%
Deferred Revenue (Current) 32,571 27,930 +16.6%
Accrued Income Taxes Current 10,770 3,706 +190.6%
Operating Lease Liability Current 14,098 12,920 +9.1%
Other Liabilities Current 1,645 2,151 -23.5%
Total Current Liabilities 175,849 159,379 +10.3%
Non-Current Liabilities
Deferred Tax Liabilities 6,169 55,863 -89.0%
Operating Lease Liabilities 83,960 87,618 -4.2%
Other Non-Current Liabilities 27,082 13,157 +105.8%
Other Liabilities
Long Term Debt And Capital Lease Obligations 346,000 319,000 +8.5%
Stockholders' Equity
Common Stock 1,550 1,582 -2.0%
Additional Paid In Capital Common Stock 911,089 820,337 +11.1%
Retained Earnings 1,066,049 1,325,247 -19.6%
Accumulated Other Comprehensive Income -59,880 -78,316 +23.5%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1,918,808 2,068,850 -7.3%
Show Equity Components breakouts
Accumulated Net Unrealized Investment Gain Loss 2,536 8,102 -68.7%
Accumulated Other Comprehensive Income -59,880 -78,316 +23.5%
Accumulated Translation Adjustment -62,416 -86,418 +27.8%
Additional Paid In Capital 911,089 820,337 +11.1%
Common Stock 1,550 1,582 -2.0%
Retained Earnings 1,066,049 1,325,247 -19.6%
Total Liabilities & Equity 2,557,868 2,703,867 -5.4%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation & Amortization 27,111 28,057 -3.4%
Fair Value Write Up Of Acquired Inventory 197 179 +10.1%
Show — breakouts
Fair Value Write Up Of Acquired Inventory 197 179 +10.1%
Deferred Income Taxes And Tax Credits -32,282 -9,551 -238.0%
Stock-Based Compensation 4,550 7,063 -35.6%
Equity Method Investment Realized Gain Loss On Disposal -1,107 799 -238.5%
Noncash Portion Of Lease Expense 183 -124 +247.6%
Impairment Of Long Lived Assets To Be Disposed Of 84,158 15,925 +428.5%
Other Operating Activities Cash Flow Statement 148 -121 +222.3%
Increase Decrease In Accounts And Other Receivables 28,861 -17,922 +261.0%
Change in Inventory -6,604 -4,616 -43.1%
Increase Decrease In Prepaid Expense -7,155 -1,163 -515.2%
Increase Decrease In Accounts Payable And Accrued Liabilities -13,315 18,609 -171.6%
Increase Decrease In Employee Related Liabilities 3,402 5,455 -37.6%
Increase Decrease In Accrued Income Taxes Payable 16,381 -10,599 +254.6%
Net Cash from Operations 98,201 75,496 +30.1%
Deferred Income Taxes (Q) — — —
Show Equity Components breakouts
Accumulated Other Comprehensive Income -0.2 -0.4 +50.0%
Investing Activities
Proceeds From Sale Of Available For Sale Securities Debt 0 4,324 -100.0%
Capital Expenditures -4,890 -17,980 +72.8%
Net Cash from Investing 406 -8,808 +104.6%
Financing Activities
Payments Of Dividends Common Stock -12,387 -12,627 +1.9%
Proceeds From Stock Options Exercised 6,226 22,934 -72.9%
Share Repurchases -100,057 0 —
Proceeds From Long Term Lines Of Credit 66,000 0 —
Repayments Of Lines Of Credit -50,000 -70,000 +28.6%
Tax Withholding for Share Compensation -234 -402 +41.8%
Net Cash from Financing -90,452 -60,095 -50.5%
Supplemental
Interest Paid 4,723 2,109 +123.9%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 13,361 5,283 +152.9%
Net Change in Cash 21,516 11,876 +81.2%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 162,186 151,791 +6.8%

Values in thousands USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key